The role of the androgen receptor in the pathogenesis of obesity and its utility as a target for obesity treatments
Year: 2022
Type: review
Abstract: Obesity is associated with hypothalamic-pituitary-testicular axis dysregulation in males. Here, we summarize recent evidence derived from clinical trials and studies in preclinical animal models regarding the role of androgen receptor (AR) signaling in the pathophysiology of males with obesity. We also discuss therapeutic strategies targeting the AR for the treatment of obesity and their limitations and provide insight into the future research necessary to advance this field.
Source: Obesity Reviews
DOI: 10.1111/obr.13429
Institutions: The University of Melbourne, Austin Health, Austin Hospital
Language: English
Subfield: Endocrinology, Diabetes and Metabolism
Field: Medicine
Domain: Health Sciences
Open Access status: hybrid
Estimated APC paid: $4,800
Funder: University of Melbourne
OpenAlex ID: W4210812833
